Hypertension Control Program in Argentina (HCPIA)
Comprehensive Approach for Hypertension Prevention and Control in Argentina
1 other identifier
interventional
1,954
1 country
1
Brief Summary
The objective of this cluster randomized trial is to test whether a comprehensive intervention program within a national public primary care system will improve hypertension control among uninsured hypertensive patients and their families in Argentina.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hypertension
Started Jun 2013
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2013
CompletedFirst Posted
Study publicly available on registry
April 17, 2013
CompletedStudy Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedJuly 17, 2017
July 1, 2017
3.3 years
April 13, 2013
July 12, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Net change in systolic (SBP) and diastolic BP (DBP) from baseline to month 18 between the intervention and control groups among hypertensive study participants.
Three BP measurements will be obtained at each data collection visit by study nurses who are masked to clinic assignment. BP will be measured according to a standard protocol recommended by the American Heart Association. The average of the three measurements will be used to compare the change over 18 months between the intervention and control groups.
Baseline and 18 months
Secondary Outcomes (6)
Proportion of hypertension control (BP<140/90 mmHg) among hypertensive patients
Baseline and 18 months
Self-reported medication adherence among hypertensive patients
Baseline and 18 months
Cost-effectiveness of the intervention
Baseline and 18 Months
Net change in systolic (SBP) and diastolic BP (DBP) from baseline to month 18 between the intervention and control groups among normotensive study participants
Baseline and 18 months
Net change in body weight and waist circumference from baseline to 18 months
Baseline and 18 months
- +1 more secondary outcomes
Study Arms (2)
Usual Care
NO INTERVENTIONClinics assigned to usual care will not receive any of the intervention components. Physicians in these clinics will continue to treat patients using their usual methods. Participants from these clinics will not receive community health worker visits or the mobile health intervention
Comprehensive Intervention
EXPERIMENTAL1. Physicians will receive training in the use of treatment algorithms based on hypertension guidelines. 2. Community health workers (CHW) will be trained in facilitating behavioral change through BP monitoring, medication management, and lifestyle modifications. CHW will serve as a source of education, motivation, and social support, and as facilitators of healthcare utilization for participants. CHW will conduct home visits, schedule appointments with primary care physicians, deliver antihypertensive medications to patients' homes, and provide tailored counseling to address barriers to behavior change. 3. Individualized text messages to promote lifestyle changes and reminders to reinforce medication adherence will be sent to participants weekly.
Interventions
The comprehensive intervention includes physician education, a community health worker home intervention and a mobile health intervention. Please see Arm Description for details.
Eligibility Criteria
You may qualify if:
- The clinic is affiliated with the Remediar+Redes program.
- The clinic is located in urban poor areas according to the 2010 census data.
- The clinic has ≥1000 outpatient visits each month, so that sufficient participants can be recruited.
- The minimum distance between the selected clinics will be 10 kilometers to minimize the risk for contamination of the intervention.
- Physician visits and essential medications are free of charge to patients under all circumstances.
- The clinic has a high number of prescriptions for antihypertensive medications.
- The clinic employs community health workers.
- The clinic has general practitioners and nurses.
- The clinic has a history of good performance in the Remediar+Redes program.
- The clinic performs blood draws on patients when appropriate.
- Patients aged ≥21 years who received primary care from the participating clinics and have hypertension ( SBP ≥140 mmHg and/or DBP ≥90 mmHg on at least 2 separate visits) and their spouses (with or without hypertension) and/or any adult hypertensive family members (age ≥21 years) living in the same household will be included.
- Hypertension patients and their spouses and/or family members must be available for the first baseline nurse home visit.
- The index patient must have a cell phone that receives text messages.
- The family's homes must be located within 10 kilometers from the clinic.
You may not qualify if:
- Hypertension patients who do not have a spouse or another adult with hypertension in the household.
- Plans to move from the neighborhood in the next two years
- Pregnant women or women who are planning to become pregnant in the next two years
- Persons who are bed-bound
- Persons who cannot give informed consent
- Persons with an arm circumference \>50 cm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Clinical Effectiveness and Health Policy
Buenos Aires, C1414CPV, Argentina
Related Publications (5)
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016 Aug 9;134(6):441-50. doi: 10.1161/CIRCULATIONAHA.115.018912.
PMID: 27502908BACKGROUNDMills KT, Rubinstein A, Irazola V, Chen J, Beratarrechea A, Poggio R, Dolan J, Augustovski F, Shi L, Krousel-Wood M, Bazzano LA, He J. Comprehensive approach for hypertension control in low-income populations: rationale and study design for the hypertension control program in Argentina. Am J Med Sci. 2014 Aug;348(2):139-45. doi: 10.1097/MAJ.0000000000000298.
PMID: 24978148RESULTPalmer MJ, Machiyama K, Woodd S, Gubijev A, Barnard S, Russell S, Perel P, Free C. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults. Cochrane Database Syst Rev. 2021 Mar 26;3(3):CD012675. doi: 10.1002/14651858.CD012675.pub3.
PMID: 33769555DERIVEDPoggio R, Melendi SE, Beratarrechea A, Gibbons L, Mills KT, Chen CS, Nejamis A, Gulayin P, Santero M, Chen J, Rubinstein A, He J, Irazola V. Cluster Randomized Trial for Hypertension Control: Effect on Lifestyles and Body Weight. Am J Prev Med. 2019 Oct;57(4):438-446. doi: 10.1016/j.amepre.2019.05.011. Epub 2019 Aug 29.
PMID: 31473065DERIVEDHe J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, Chen CS, Gibbons L, Krousel-Wood M, Bazzano LA, Nejamis A, Gulayin P, Santero M, Augustovski F, Chen J, Rubinstein A; HCPIA Investigators. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial. JAMA. 2017 Sep 19;318(11):1016-1025. doi: 10.1001/jama.2017.11358.
PMID: 28975305DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiang He, MD, PhD
Tulane University Health Sciences Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair, Department of Epidemiology
Study Record Dates
First Submitted
April 13, 2013
First Posted
April 17, 2013
Study Start
June 1, 2013
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
July 17, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Immediately after main paper published.
Our study data sharing plan will comply with all NIH policies for data sharing. Sharing of data and scientific findings with the research and clinical communities will be executed through the centralized NIH data repository, publications in peer reviewed journals, and presentations at scientific meetings. Data sharing will be implemented in a timely manner. The study data, including data from baseline and follow-up visits, will be prepared for transmission to the NHLBI data repository beginning two years after the last subject completes the study visit. These data will be free of identifiers that allow identification of individual research participants either directly or through "deductive disclosure." In addition, we will offer through our public access website opportunities for outside investigators to collaborate with us using the complete study data and samples.